Difference between revisions of "Atovaquone (Mepron)"
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
m |
||
| Line 11: | Line 11: | ||
==Patient drug information== | ==Patient drug information== | ||
*[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand name:''' Mepron | ||
==References== | ==References== | ||
Revision as of 15:13, 23 July 2018
General information
Class/mechanism: Antiprotozoal, antimicrobial. Hydroxy-1,4-naphthoquinone, analog of ubiquinone, with antipneumocystis activity. Exact mechanism unclear, but may involve inhibition of the electron transport chain in mitochondria and downstream inhibition of nucleic acid and ATP synthesis.[1][2]
Route: PO (typically as liquid suspension)
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
No known antineoplastic properties.
Patient drug information
Also known as
- Brand name: Mepron